Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verweij

Showing results (151-160 of 655) with videos related to

Pageof 66
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neckA S Planting, P H de Mulder, A de Graeff, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 11, 2003
[Imatinib, a specific tyrosine-kinase inhibitor, for the treatment of patients with a gastrointestinal stroma cell tumor]H Gelderblom, P C Hogendoorn, W T van der Graaf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Phase II study of ACNU as first-line treatment in advanced colorectal cancerA Planting, A Hoff, M van der Burg, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Abrogated energy-dependent uptake of cisplatin in a cisplatin-resistant subline of the human ovarian cancer cell line IGROV-1J Ma, M Maliepaard, H J Kolker, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1990
Combination therapy of ACNU and ifosfamide in tumor bearing mice with M2661 breast cancer, B16 malignant melanoma or C38 colon cancerM H Silbermann, B vd Vecht, G Stoter, et al.
Critical Reviews in Oncology/Hematology|April 17, 2009
Aurora kinase inhibitorsJ J E M Kitzen, M J A de Jonge, J Verweij
European Journal of Cancer (Oxford, England : 1990)|March 26, 2003
Lack of c-kit exon 11 activating mutations in c-KIT/CD117-positive SCLC tumour specimensH Burger, M A den Bakker, G Stoter, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2005
RECIST vs. WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcomaP Therasse, A Le Cesne, M Van Glabbeke, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1995
Measurement of antibody response to keyhole limpet haemocyanin was not adequate for early diagnosis of schistosomiasis in a group of Dutch visitors to MaliJ J Verweij, A M Polderman, L G Visser, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 22, 2004
[Outbreak of amoebiasis in a Dutch family; tropics unexpectedly nearby]W M Edeling, J J Verweij, C Ij Ponsioen, et al.
Pageof 66

Showing results (151-160 of 655) with videos related to

Sort By:
Pageof 66
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neckA S Planting, P H de Mulder, A de Graeff, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 11, 2003
[Imatinib, a specific tyrosine-kinase inhibitor, for the treatment of patients with a gastrointestinal stroma cell tumor]H Gelderblom, P C Hogendoorn, W T van der Graaf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1991
Phase II study of ACNU as first-line treatment in advanced colorectal cancerA Planting, A Hoff, M van der Burg, et al.
Cancer Chemotherapy and Pharmacology|January 27, 1998
Abrogated energy-dependent uptake of cisplatin in a cisplatin-resistant subline of the human ovarian cancer cell line IGROV-1J Ma, M Maliepaard, H J Kolker, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1990
Combination therapy of ACNU and ifosfamide in tumor bearing mice with M2661 breast cancer, B16 malignant melanoma or C38 colon cancerM H Silbermann, B vd Vecht, G Stoter, et al.
Critical Reviews in Oncology/Hematology|April 17, 2009
Aurora kinase inhibitorsJ J E M Kitzen, M J A de Jonge, J Verweij
European Journal of Cancer (Oxford, England : 1990)|March 26, 2003
Lack of c-kit exon 11 activating mutations in c-KIT/CD117-positive SCLC tumour specimensH Burger, M A den Bakker, G Stoter, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2005
RECIST vs. WHO: prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcomaP Therasse, A Le Cesne, M Van Glabbeke, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 1, 1995
Measurement of antibody response to keyhole limpet haemocyanin was not adequate for early diagnosis of schistosomiasis in a group of Dutch visitors to MaliJ J Verweij, A M Polderman, L G Visser, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 22, 2004
[Outbreak of amoebiasis in a Dutch family; tropics unexpectedly nearby]W M Edeling, J J Verweij, C Ij Ponsioen, et al.
Pageof 66